DLX2 Antikörper (Middle Region)
Kurzübersicht für DLX2 Antikörper (Middle Region) (ABIN452916)
Target
Alle DLX2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody detects DLX2 at Center.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human DLX2
-
-
-
-
Applikationshinweise
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- DLX2 (Distal-Less Homeobox Protein 2 (DLX2))
-
Andere Bezeichnung
- DLX2
-
Hintergrund
- DLX2 is likely to play a regulatory role in the development of the ventral forebrain. It may play a role in craniofacial patterning and morphogenesis. Subcellular location: Nucleus (Potential).Synonyms: DLX-2, Homeobox protein DLX2
-
Molekulargewicht
- 34243 Da
-
Gen-ID
- 1746
-
NCBI Accession
- NP_004396
-
UniProt
- Q07687
Target
-